<DOC>
	<DOCNO>NCT00721695</DOCNO>
	<brief_summary>This exploratory study determine safety clinical benefit OMS302 Injection subject undergoing Cataract Extraction Lens Replacement ( CELR ) use coaxial phacoemulsification process .</brief_summary>
	<brief_title>Exploratory Study OMS302 Injection Subjects Undergoing Unilateral Cataract Extraction Phacoemulsification .</brief_title>
	<detailed_description>OMS302 Injection mydriatic/anti-inflammatory combination investigational drug product develop irrigation solution intracameral lens replacement surgical procedure eye . OMS302 irrigation solution may induce maintain adequately dilated pupil reduce postoperative symptom discomfort eye pain irritation . The use OMS302 irrigation solution may eliminate need pre-operative dilation eye could reduce postoperative use anti-inflammatory pain medication follow surgery .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Mydriatics</mesh_term>
	<criteria>Subject 50 year age old . Subject undergo unilateral primary CELR agerelated cataract topical anesthesia use clear cornea incision . Subject 's history physical examination within normal limit examination clinically nonsignificant purpose study determine Investigator , subject good general health . Subject best correct visual acuity ( BCVA ) 20/400 good nonstudy eye . Subject intraocular pressure ( IOP ) 5 mmHg 22 mmHg , inclusive , study eye . Subject allergic individual ingredient OMS302 Subject take medication activity active ingredient OMS302 define time interval prior surgery . Female subject childbearing potential ( i.e. , surgically sterilize postmenopausal longer one year ) use effective method birth control within least 14 day prior surgery positive pregnancy test . Subject present condition history clinically significant uncontrolled gastrointestinal , cardiovascular , hepatic , renal , hematological , endocrine , neurological , psychiatric , connective tissue , respiratory , medical disorder determine Investigator . Subject take anticoagulant . Subject take need take duration study prohibit medication . Subject pseudocapsular exfoliation , evidence prior iritis ocular trauma iris damage , use pilocarpine within six month screen . Subject uncontrolled chronic ocular disease . Subject active corneal pathology scar note either eye ( except superficial punctate keratopathy nonstudy eye ) . Subject extraocular/intraocular inflammation either eye . Subject active bacterial and/or viral infection either eye . Subject narrowangle glaucoma , unstable glaucoma , glaucoma treat prostaglandin prostaglandin analogue . Subject taking , take within past year , alpha adrenergic antagonist . Subject participate currently participate investigational drug device trial within previous 30 day prior day surgery . Subject intraocular conventional surgery within past three month intraocular laser surgery within one month plan surgery study eye . Subject require use topical medication trial except prophylactic antibiotic , topical lid care glaucoma medication tear replacement solution . Subject need ocular surgery time cataract extraction .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Cataract</keyword>
	<keyword>Cataract Extraction</keyword>
	<keyword>Lens Implantation</keyword>
	<keyword>Phacoemulsification</keyword>
</DOC>